| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group | 
| Cocaine (as cocaine hydrochloride) 20 mg/mL and homatropine hydrobromide 20 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely prednisolone (as prednisolone sodium phosphate) 3 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely mercaptamine 1 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Cyclopentolate hydrochloride 10 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Phenoxymethylpenicillin potassium 3 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Cyclopentolate hydrochloride 20 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely polyvinyl alcohol 14 microliter/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Hydrocortisone acetate 15 mg/mL and neomycin (as neomycin sulfate) 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Phenylephrine hydrochloride 25 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely atropine sulfate 310 microgram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Atropine sulfate 620 microgram/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Atropine sulfate 1 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely atropine sulfate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Cyclopentolate hydrochloride 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Ecothiopate iodide 300 microgram/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Oxymetazoline hydrochloride 500 microgram/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely ecothiopate iodide 600 microgram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Ecothiopate iodide 2.5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely physostigmine salicylate 5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Glycerol 10 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Ecothiopate iodide 1.25 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| karboximetylcellulosanatrium 5 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Tetracaine hydrochloride 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Tetracaine hydrochloride 10 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely tetracaine hydrochloride 20 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Glycerol 500 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| karboximetylcellulosanatrium 10 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline 1 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline 2.5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Methylcellulose 10 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Hyoscine (as hyoscine hydrobromide) 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| tropikamid 5 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| tropikamid 10 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Lomefloxacin 3 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely carbachol 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Hypromellose 3.2 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Carbachol 15 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Adrenaline (as adrenaline acid tartrate) 500 microgram/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely guanethidine 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Guanethidine 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely propamidine isethionate 1 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely guanethidine 20 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely guanethidine 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely guanethidine 30 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| apraklonidin (som apraklonidinhydroklorid) 10 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Levobunolol hydrochloride 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Povidone 50 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Cocaine (as cocaine hydrochloride) 200 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| timolol (som timololmaleat) 2,5 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely cromoglicate sodium 20 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| timolol (som timololmaleat) 5 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Dibrompropamidine isetionate 1 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely cocaine (as cocaine hydrochloride) 40 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Metipranolol 1 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Metipranolol 3 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely levofloxacin anhydrous (as levofloxacin) 15 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Levofloxacin anhydrous (as levofloxacin) 5 mg/mL eye solution | Has manufactured dose form | True | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| azitromycin, vattenfritt (som azitromycinmonohydrat) 10 milligram/milliliter, lösning för oftalmiskt bruk | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  | 
| Product containing precisely azithromycin 10 milligram/1 milliliter conventional release eye solution (clinical drug) | Has manufactured dose form | False | Conventional release eye solution (dose form) | Inferred relationship | Some |  |